IMD business school for management and leadership courses

Sanofi is pursuing a bold, enterprise-wide strategy to embed AI at every level of its operations. Central to this vision is a pioneering alliance with OpenAI and Formation Bio, focused on co-developing customized large language model (LLM) agents trained on Sanofi’s proprietary data. These models power tools like Muse, which automates multilingual patient recruitment materials and debuts in a Phase 3 multiple sclerosis trial. 

Sanofi’s Snackable AI architecture supports over 10,000 predictive insights daily, enhances clinical document automation, and fuels internal tools such as an AI concierge and a generative AI-driven launch planning system. The company also deploys AI across sales enablement (e.g., Quantified.ai Sales Simulator), safety reporting (via Project ARTEMIS with IQVIA), and workforce mobility (through the Workday® Career Hub). 

Ethical AI adoption is governed by a Responsible AI Working Committee and an Accountable to Outcomes framework, ensuring transparency, fairness, safety, and sustainability. With a dedicated AI Risk Assessment, internal governance structures, and large-scale employee training programs, Sanofi is executing one of the most integrated AI transformation agendas in global biopharma.